Submit ICO / Airdrop ★ Get Promotion
ProjectsDeFiAirdropsSTOsPromotionMarks newsWatchlist ()
0
Little Rat

Little Rat

PRE-SALE ENDED
793 Views
Visit Website
Last screenshot taken on
21 Feb 2023 .
Add to Watchlist
With $RAT being the core utility token, we are putting an emphasis on a fully decentralized technology.

$RAT will focus on providing a user-friendly, cross-chain DEX known as: $RAT Swap.

Providing traders the option to preset the gas price and gas limit - aswell as an option to adjust the slippage up to 100% which will increase the probability of a successful transaction.
Smart Contract
2.5
TOTAL SCORE
1.9
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
Pre-sale Time: unknown - 23 Apr 2023
Token info
Ticker: RAT
Platform: Binance Chain
Financial
Social media
Twitter
Telegram
Discord
HORIZONTAL
SQUARE
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Allabout.me
A DIGITAL NETWORK USER = A CRYPTOCURRENCY BANK CLIENT Allabout.me is the first social network based on Bitcoin and the internal token of the project ALL.ME. All.me built-in a personal wallet in every user's account. A person creates an account and becomes a client of the internal cryptocurrency bank.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
Invictus Margin Lending
The Invictus Margin Lending Fund offers investors the ability to take advantage of the volatile nature of the cryptocurrency market without risking direct exposure. The fund aims to maximize interest income on USD and USD equivalents with zero anticipated drawdown risk by taking dollar-based positions on margin lending platforms.
Active
Zillios
Zillios is the next generation international real estate platform, revolutionary and highly innovative. Zillios completely changes the way the real estate market operates providing a state of the art scalable infrastructure to all key stakeholders, including smart contract based features to tackle current inefficiencies in rental and buying processes. Blockchain-based property transfer is foreseen in Zillios´ technology providing a future-proof infrastructure.
Upcoming
Coolomat
Coolomat Market will change the online e-commerce grocery sector with an innovative approach connecting customers and producers, big and small, over a new innovative online platform utilizing blockchain technology and open source software. A big “game changer” is the connection to physical click & collect pick up point devices – Coolomats. Our devices present the first and the only worldwide network of such kind.